­

December 2014

ActiveCare® in CCJR 2014: Just Say No to Drugs" ActiveCare® participated in CCJR 2014, Current Concepts in Joint Replacement, held in Florida, Dec 10-14. During this conference, leading orthopedic surgeon [...]

June 2014

ActiveCare® at EFORT 2014 Congress in London Over 7000 colleagues attended the Annual Congress of The European Federation of National Associations of Orthopaedics and Traumatology (EFORT). ActiveCare® attracted the attention of many orthopedic surgeons [...]

March 2014

ActiveCare® received an incredible push forward by leading orthopedic surgeons during AAOS American Academy of Orthopaedic Surgeons 2014, the largest academic conference on orthopedic surgery, which was held in March in [...]

February 2014

Activecare® gets professional recognition: Research on the device is published as a leading article in the most prestige journal JBJS. A special commentary is dedicated to this research in the Feb [...]

December 2013

When an Israeli company nears the sales stage, the debate whether it is time to hire an American CEO almost always begins. A man who knows the target market, has [...]

October 2013

Dr. Robert Barrack in the Charnley Lecture at 2013 BOA Annual Congress: “It is the First Time That the US Deep Vein Thrombosis (DVT) Prevention Guidelines Have Been Modified for [...]

September 2013

You can now follow us on Twitter for the most recent updates on DVT prevention in orthopedic surgery. MCS presents a new video for orthopedic surgeons.

August 2013

MCS presents a new video for patients undergoing joint replacement surgery. Follow MCS on LinkedIn for the most recent company news and updates!

March 2013

"In View" with Larry King showcasing ActiveCare® therapy. ActiveCare® - alternative to anticoagulants for Deep Vein Thrombosis prevention during or after Total Joint Replacement (TJR), Total Knee Replacement (TKR) or Total [...]

December 2010

According to Adi Dagan, MCS’s CEO: “The use of the company’s device by America’s number one orthopedic hospital, HSS, is the jewel in the crown that has been added to the leading [...]

June 2010

MCS Expands into South Korea MCS Wins another Minnesota Medical Center in May

April 2010

Approximately 2,000 relevant medical procedures are performed annually at these medical centers, and MCS expects its penetration rate to reach about 20% in the first year. MCS Continues to Expand [...]

More clinical studies:

Compliance in Trauma Patients
M. Murakami, T. McDill, L. Cindrick-Pounds, D. Loran, K. Woodside, W. Mileski,
G. Hunter and L. Killewich
Deep Venous Thrombosis Pophylaxis in Trauma: Improved Compliance With a Novel Miniaturized Pneumatic Compression Device
Journal of Vascular Surgery, November 2003; 38(5): 923-927

Compliance in Gynecologic Patients 
M. Kahan, C. Lord, M. Murakami, J. Lucci, L. Killewich
Deep Venous Thrombosis Prophylaxis in Gynecologic Surgery:
Improved Compliance With a Novel Miniaturized Pneumatic  Compression Device
Journal of Pelvic Medicine and Surgery, 2003; 9 (sup 1)

ActiveCare®+Enoxaparin vs Enoxaparin
G. Rosenthal, F. Umansky, S. Goldman, G. Spector, D. Varone, Y. Weiss, M. Brazis
How to Prevent Venous Thromboembolism After Brain Surgery?
Quality Saves Costs.
Hadassah Medical Center – Ein Karem, Israel

Fill in this form and we'll get back to you

Your title:

First Name:
Last Name:
Phone:
Email:


lower
the
risk.

cut
the
cost.